Free tool
Cell therapy stocks
We cover 5 companies grouped under the Cell therapy theme. The median market value in the group is $415.26M. Across the group, the median move over the past trading day is −1.77%. Price change over the past year runs from −26.2% to +170.5% across the middle 80 percent of the group, with a median of +17.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| SYNC.L | Syncona Limited | 112.00 GBP | +4.67% | +17.28% | +17.03% |
| 0JDK.L | Iovance Biotherapeutics, Inc. | $8.19 | −2.04% | +216.33% | +265.60% |
| 0HX7.L | Adicet Bio, Inc. | $8.87 | −1.22% | +3.14% | −28.19% |
| ALCLS.PA | Cellectis S.A. | 2.94 EUR | +16.59% | −30.30% | +27.74% |
| 0HIY.L | Atara Biotherapeutics, Inc. | $9.58 | −1.90% | −46.57% | −23.28% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.